| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |